Beacon Investment Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,905
| Closed | -$681K | – | 251 |
|
|
2024
Q4 | $681K | Sell |
18,905
-13,705
| -42% | -$494K | 0.03% | 153 |
|
|
2024
Q3 | $1.38M | Sell |
32,610
-970
| -3% | -$41.1K | 0.06% | 129 |
|
|
2024
Q2 | $1.35M | Sell |
33,580
-2,883
| -8% | -$116K | 0.06% | 126 |
|
|
2024
Q1 | $1.29M | Sell |
36,463
-1,467
| -4% | -$51.9K | 0.06% | 126 |
|
|
2023
Q4 | $1.12M | Sell |
37,930
-4,031
| -10% | -$119K | 0.05% | 134 |
|
|
2023
Q3 | $872K | Sell |
41,961
-779
| -2% | -$16.2K | 0.04% | 153 |
|
|
2023
Q2 | $1.05M | Buy |
42,740
+17,326
| +68% | +$425K | 0.05% | 152 |
|
|
2023
Q1 | $1.03M | Sell |
25,414
-3,710
| -13% | -$151K | 0.05% | 147 |
|
|
2022
Q4 | $1.31M | Buy |
29,124
+2,215
| +8% | +$99.6K | 0.07% | 136 |
|
|
2022
Q3 | $1.29M | Buy |
26,909
+4,359
| +19% | +$209K | 0.07% | 134 |
|
|
2022
Q2 | $1.34M | Buy |
22,550
+1,126
| +5% | +$66.7K | 0.07% | 135 |
|
|
2022
Q1 | $2.49M | Buy |
21,424
+1,622
| +8% | +$189K | 0.11% | 121 |
|
|
2021
Q4 | $2.98M | Buy |
19,802
+1,618
| +9% | +$244K | 0.12% | 121 |
|
|
2021
Q3 | $2.17M | Buy |
18,184
+3,568
| +24% | +$426K | 0.09% | 130 |
|
|
2021
Q2 | $1.42M | Buy |
14,616
+1,725
| +13% | +$168K | 0.06% | 151 |
|
|
2021
Q1 | $1.14M | Buy |
12,891
+3,487
| +37% | +$308K | 0.05% | 156 |
|
|
2020
Q4 | $900K | Buy |
9,404
+3,092
| +49% | +$296K | 0.04% | 155 |
|
|
2020
Q3 | $716K | Buy |
6,312
+407
| +7% | +$46.2K | 0.04% | 154 |
|
|
2020
Q2 | $584K | Buy |
5,905
+1,509
| +34% | +$149K | 0.03% | 160 |
|
|
2020
Q1 | $283K | Buy |
+4,396
| New | +$283K | 0.02% | 199 |
|